Your session is about to expire
← Back to Search
3D Ultrasound Imaging for Breast Cancer Detection
N/A
Recruiting
Led By Shigao Chen, Ph.D.
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Adult women, ≥ 18 years of age.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights
Study Summary
This trial will test how well a new ultrasound imaging method can detect breast masses.
Who is the study for?
This trial is for adult women over 18 with a breast lesion who are scheduled for a biopsy. It's not open to those under 18, anyone with previous breast surgery or implants, those unable to consent, pregnant or breastfeeding women, or patients currently undergoing cancer treatments.Check my eligibility
What is being tested?
The study is testing the effectiveness of a new ultrasound imaging method using two different scanners: the GE Logiq E10 and the Verasonics research scanner. The goal is to see how well they diagnose breast masses compared to current methods.See study design
What are the potential side effects?
Ultrasound scanning is generally safe and does not have significant side effects. However, there might be minor discomfort due to pressure from the ultrasound probe during imaging.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am a woman aged 18 or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
BI-RADS Score
Trial Design
1Treatment groups
Experimental Treatment
Group I: Clinically indicated breast tumor biopsyExperimental Treatment2 Interventions
Subjects with breast lesion and are scheduled for clinically-indicated biopsy will have 3D Multimodal Ultrasound Imaging performed
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for breast cancer include surgery, which physically removes the tumor; radiation therapy, which uses high-energy rays to kill cancer cells; chemotherapy, which uses drugs to destroy rapidly dividing cells; hormone therapy, which blocks hormones that fuel certain cancers; and targeted therapy, which attacks specific molecules involved in cancer growth. Understanding these mechanisms helps patients and doctors choose the most effective treatment plan, especially when new diagnostic tools like 3D ultrasound imaging can provide more accurate detection and characterization of breast masses, potentially leading to more personalized and effective treatment strategies.
Impact of modern personalized treatment of breast cancer on surgical attitude and outcomes.
Impact of modern personalized treatment of breast cancer on surgical attitude and outcomes.
Find a Location
Who is running the clinical trial?
Mayo ClinicLead Sponsor
3,250 Previous Clinical Trials
3,785,233 Total Patients Enrolled
83 Trials studying Breast Cancer
13,796 Patients Enrolled for Breast Cancer
United States Department of DefenseFED
872 Previous Clinical Trials
329,765 Total Patients Enrolled
38 Trials studying Breast Cancer
103,475 Patients Enrolled for Breast Cancer
Shigao Chen, Ph.D.Principal InvestigatorMayo Clinic
1 Previous Clinical Trials
50 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am under 18 years old.I am a woman aged 18 or older.I have a breast lump and am scheduled for a biopsy.I am unable to understand or make decisions about my treatment.I have had breast surgery or have a breast implant.I am currently undergoing cancer treatment like chemotherapy or radiation.
Research Study Groups:
This trial has the following groups:- Group 1: Clinically indicated breast tumor biopsy
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger